VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) was up 76.5% on Friday . The stock traded as high as C$0.16 and last traded at C$0.15. 3,992,349 shares were traded during trading, an increase of 1,549% from the average daily volume of 242,055 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Down 23.3 %
The company has a market cap of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The business has a 50-day simple moving average of C$0.10 and a two-hundred day simple moving average of C$0.13. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- What Are Treasury Bonds?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 5 Best Gold ETFs for March to Curb Recession Fears
- Dividend Payout Ratio Calculator
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
